Cardior Pharmaceuticals - a Novo Nordisk company
@CardiorPharma
Followers
219
Following
9
Media
122
Statuses
141
Cardior is a leading clinical-stage biopharmaceutical company pioneering RNA-based therapeutics designed to address the root causes of cardiac dysfunction.
Hannover, DE
Joined June 2021
Last night, our CEO @ClaudiaUlbrich_ was recognized by @wiwo as one of Germany’s 30 by 2030, driving innovation in Germany as serial biotech entrepreneur! Join us in congratulating Claudia and access the recording here:
de.linkedin.com
🌟🚀 WirtschaftsWoche Mutmacher - Deutschlands 30 bis 2030 🚀🌟 Mit der Initiative „Deutschlands 30 bis 2030“ ehrt die WirtschaftsWoche inspirierende Persönlichkeiten, die unser Land in den kommen...
0
0
0
Proud to announce that our CEO and Co-Founder, @ClaudiaUlbrich_ has been named one of “Deutschlands 30 bis 2030” by @wiwo: https://t.co/dMYDvagWsb Looking forward to connecting with pioneering minds from Germany at the #HMGWinterCamp in Düsseldorf.
0
0
0
Our CSO/CMO and Founder @ThomasThum_TH2 will attend the #CVCT Forum 2024 in Washington DC, bringing together global cardiovascular experts and key stakeholders. Looking forward to insightful presentations and discussions! #cvct2024 #clinicalresearch #clinicaltrials
0
0
3
Earlier this month, @ClaudiaUlbrich_ moderated the panel “Biomedical Innovation Ecosystems: Recipes for Success” at the @Falling_Walls Science Summit 2024, to discuss how collaboration, cutting-edge research, and strategic investment are driving breakthroughs in #LifeSciences
1
0
0
Our CEO, @ClaudiaUlbrich_ , will attend the 34th Frankfurt European Banking Congress, where she will join experts across different sectors in exploring Europe’s role in the global landscape. Reach out if you are also attending and want to connect! #EuropeanBankingCongress
0
0
0
Our CEO, @ClaudiaUlbrich_ will join a panel at HQ Trust Investors Forum 2024 during Euro Finance Week. She’ll share insights on Cardior’s recent acquisition by Novo Nordisk as an example of adding impact to returns for investing into innovation. #EuroFinanceWeek #HQTrustForum
0
0
0
Our CEO, Dr. Claudia Ulbrich, and CSO/CMO Dr. Thomas Thum will be engaging in key discussions on the future of healthcare with global leaders across the industry. If you're attending, let’s connect! #FallingWalls #ScienceSummit24
0
1
3
We are excited that Cardior Pharmaceuticals' CEO and Co-Founder Dr. Claudia Ulbrich is invited to speak at BioMed Life Science Day organized by BioMed Partners in Basel, Switzerland on October 31, 2024.
0
0
0
Cardior Pharmaceuticals’ CEO and Co-Founder Dr. Claudia Ulbrich is in Oslo this week to take part in Hadean Investment Event 2024 organized by #Hadeanventures held in the world famous #Munchmuseeum on October 23-24.
0
0
1
Dr. Sandor Batkai, @CardiorPharma's Co-founder & Head of Medical Research and Intelligence, is presenting at the 3rd Annual Heart Failure Drug Discovery & Development Summit in Boston, MA on Aug 1, 2024. Check the agenda for more and stop by: https://t.co/Jy4olZRj1q
0
0
0
We congratulate Vicente Godoy on the promotion to Vice President Quality Management & Compliance and welcome him to @CardiorPharma Leadership Team!
0
0
1
We are happy to announce @ThomasThum_TH2 and Dr. @ClaudiaUlbrich_ are among the finalists of Andreas & Thomas Struengmann Award, the first of its kind in the DACH region aimed at recognizing entrepreneurial achievements in the life sciences arena: https://t.co/9s70350Pp2
1
1
8
@CardiorPharma CEO Dr. @ClaudiaUlbrich_ is participating in @DemiColton Biotech CEO Summit Europe in Barcelona, Spain on May 27-29, 2024. On Monday May 27 Claudia is invited to speak at Fireside Chat moderated by @PKOZA of Blue Matter. To learn more: https://t.co/MpoTmBtKlc
0
1
2
Cardior’s founder and CSO/CMO Prof. @ThomasThum_TH2 will present the exciting journey starting from research on #microRNAs at the bench to clinical testing in heart failure and the potential of #CDR132L to tackle the root causes of acute and chronic HF: https://t.co/BIx1oEIigk
0
3
11
Here’s a teaser to a new episode from Hannover 🇩🇪 with Claudia Ulbrich, CEO and co-founder of @CardiorPharma. Hear the details about Cardior’s recent €1B exit to @novonordisk, miRNA/Cardiovascular and more. Watch on YouTube, Spotify or Apple. What do you think? 🤔
1
4
3
Watch our CEO, @ClaudiaUlbrich_, in the @Flotbio podcast where she discussed the recent €1B acquisition of Cardior by @novonordisk . The episode is a deep dive into @CardiorPharma story and acquisition and the inspiring career of Dr. Claudia Ulbrich:
0
0
6
As of May 2, 2024 @CardiorPharma has become a fully owned subsidiary of @novonordisk. Happy to combine forces with Novo Nordisk to accelerate the clinical development of our lead compound with the aim of bringing life-saving treatment to heart patients! Two teams in Hannover.
0
4
11
@CardiorPharma's CEO Dr. @ClaudiaUlbrich_ is participating in German Biotech Days 2024 taking place in Berlin on April 16-17. It is the best place to feel the pulse of German biotech and a perfect meeting point for science and business.
0
1
2
On Wednesday April 17 @ThomasThum_TH2, Professor of @MHH_life and @CardiorPharma's CSO/CMO is holding a presentation on the development of noncoding #RNA therapeutics for #CDV at @KeystoneSymp Cardiovascular Epigenetics and Gene Regulation. Learn more: https://t.co/INWmp8wHjA
0
4
13
Huge thanks from the @CardiorPharma team to all of you, our partners and friends, for your heartfelt congratulations on the potential acquisition by @novonordisk. It’s an important step towards bringing #RNA-based therapies to heart failure patients! More https://t.co/vTTZSEJU2e
0
0
10